GLP-1 Drugs Ozempic, Wegovy Linked to Rare Blinding Condition
WEDNESDAY, July 3, 2024 (HealthDay News) — Trendy weight-loss drugs appear to increase the risk of a rare and potentially blinding eye condition, a new study warns. People with diabetes prescribed semaglutide (Ozempic, Wegovy) were more than four times more likely to be diagnosed with NAION, researchers reported July 3Continue Reading